PHARVARIS NV

Pharvaris NV Insider Abele Stefan Andreas Corrects Shareholding Amid Strong Clinical Progress and Social‑Media Buzz

Pharvaris NV insider Abele Stefan Andreas adjusts holdings, boosting investor confidence amid active social‑media buzz and strong Phase 3 clinical progress.

PHARVARIS NV
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

03/04/2026, 17:15

2 minutes to read

Pharvaris NV Insider Holds Steady: CEO’s 55,000-Share Retention Signals Confidence in B2 Antagonist Pipeline

Pharvaris insider Souverijns keeps 55k shares, showing strong confidence in its B2 antagonist pipeline and a long‑term growth outlook.

PHARVARIS NV
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

18/03/2026, 21:14

10 minutes to read

Newer articles